He’s a lawyer not a doctor, and a lizard promoter selling patent elixir.
The actual doctors are not making these outlandish claims, they’re just studying it because the know the first was way too small to conclude anything yet.
It's a small sample, but it seems to be exactly what the doctors in the French study are claiming:
The proportion of patients that had negative PCR results in nasopharyngeal samples significantly differed between treated patients and controls at days 3-4-5 and 6 post-inclusion (Table 2). At day6 post-inclusion, 70% of hydroxychloroquine-treated patients were virologicaly cured comparing with 12.5% in the control group (p= 0.001). When comparing the effect of hydroxychloroquine treatment as a single drug and the effect of hydroxychloroquine and azithromyc in combination, the proportion of patients that had negative PCR results in nasopharyngeal samples was significantly different between the two groups at days 3-4-5 and 6 post-inclusion (Table 3). At day6 post-inclusion, 100% of patients treated with hydroxychloroquine and azithromycin combination were virologicaly cured comparing with 57.1% in patients treated with hydroxychloroquine only, and 12.5% in the control group (p<0.001).
It looks so promising, many other researchers are turning their attention to it in an attempt to recreate their success. Among them the University of Minnesota:
He’s a lawyer not a doctor, and a lizard promoter selling patent elixir.
The actual doctors are not making these outlandish claims, they’re just studying it because the know the first was way too small to conclude anything yet.
It's a small sample, but it seems to be exactly what the doctors in the French study are claiming:
It looks so promising, many other researchers are turning their attention to it in an attempt to recreate their success. Among them the University of Minnesota:
https://med.umn.edu/news-events/covid-19-clinical-trial-launches-university-minnesota
Probably more, this is one that caught my eye this morning.